Evidence map›Paper›PMID 25630058›Full record

ReviewVirus research2015

The 5' and 3' ends of alphavirus RNAs--Non-coding is not non-functional.

Jennifer L Hyde, Rubing Chen, Derek W Trobaugh, Michael S Diamond, Scott C Weaver, William B Klimstra, Jeffrey Wilusz

Open access · greenAbstract readReview
In one paragraph

Review in Virus research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. The advent of clinical self-amplifying RNA vaccines.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Review
  18. Article
  19. Review
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jennifer L HydeDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Rubing ChenInstitute for Human Infections and Immunity, Center for Tropical Diseases, and Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Derek W TrobaughCenter for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh, 8031 BST3, 3501 Fifth Avenue, Pittsburgh, PA 15261, USA.
Michael S DiamondDepartment of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO 63110, USA; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA. Electronic address: diamond@wusm.wustl.edu.
Scott C WeaverInstitute for Human Infections and Immunity, Center for Tropical Diseases, and Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA. Electronic address: sweaver@utmb.edu.
William B KlimstraCenter for Vaccine Research and Department of Microbiology and Molecular Genetics, University of Pittsburgh, 8031 BST3, 3501 Fifth Avenue, Pittsburgh, PA 15261, USA. Electronic address: klimistra@pitt.edu.
Jeffrey WiluszDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80523, USA. Electronic address: jeffrey.wilusz@colostate.edu.
The University of Texas Medical Branch at Galveston · USUniversity of Pittsburgh · USWashington University in St. Louis · USColorado State University · US

Funding

Vascular stabilization as a broad theraprutic platform for biodefenseU54AI065357 · NIAID · COLORADO STATE UNIVERSITY-FORT COLLINS · PI BELISLE, JOHN T · 2005 to 2013
$77.5M
West Nile Virus and host control of innate defensesU19AI083019 · NIAID · UNIVERSITY OF WASHINGTON · PI CLARK, EDWARD A · 2009 to 2018
$22.5M
Molecular Mechanisms of Eastern Equine Encephalitis Virus PathogenesisR01AI095436 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLIMSTRA, WILLIAM B · 2012 to 2022
$4.5M
Innate Immune Control of West Nile VirusR01AI104002 · NIAID · UNIVERSITY OF WASHINGTON · PI DIAMOND, MICHAEL S, GALE, MICHAEL · 2013 to 2017
$3.7M
ISG CONTROL OF FLAVIVIRUS INFECTIONR01AI104972 · NIAID · WASHINGTON UNIVERSITY · PI CHANDA, SUMIT K, DIAMOND, MICHAEL S · 2013 to 2017
$3.0M
Mechanisms of sylvatic dengue emergenceR01AI069145 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WEAVER, SCOTT C · 2008 to 2011
$2.5M
VEE Virus Infection on the Mosquito VectorR01AI071192 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI WEAVER, SCOTT C · 2008 to 2013
$2.0M
Characterization of microRNA binding sites in the eastern equine encephalitis virus 3'NTRR21AI111115 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KLIMSTRA, WILLIAM B · 2015 to 2016
$412k
NIAID NIH HHS AI069145NIAID NIH HHS AI071192NIAID NIH HHS R01 AI069145NIAID NIH HHS R01 AI071192NIAID NIH HHS R01 AI095436NIAID NIH HHS R01 AI104002NIAID NIH HHS R01 AI104972NIAID NIH HHS R21 AI111115NIAID NIH HHS U19 AI083019NIAID NIH HHS U54 AI065357NIAID NIH HHS U54AI065357
6 · The paper itself

Abstract

The non-coding regions found at the 5' and 3' ends of alphavirus genomes regulate viral gene expression, replication, translation and virus-host interactions, which have significant implications for viral evolution, host range, and pathogenesis. The functions of these non-coding regions are mediated by a combination of linear sequence and structural elements. The capped 5' untranslated region (UTR) contains promoter elements, translational regulatory sequences that modulate dependence on cellular translation factors, and structures that help to avoid innate immune defenses. The polyadenylated 3' UTR contains highly conserved sequence elements for viral replication, binding sites for cellular miRNAs that determine cell tropism, host range, and pathogenesis, and conserved binding regions for a cellular protein that influences viral RNA stability. Nonetheless, there are additional conserved elements in non-coding regions of the virus (e.g., the repeated sequence elements in the 3' UTR) whose function remains obscure. Thus, key questions remain as to the function of these short yet influential untranslated segments of alphavirus RNAs.

Indexed as

3' Untranslated Regions5' Untranslated RegionsGene Expression Regulation, ViralVirus ReplicationAlphavirusHost-Pathogen InteractionsProtein BindingProtein BiosynthesisRNA-Binding ProteinsRNA, ViralTranscription, GeneticViral Proteins3' Untranslated Regions5' Untranslated RegionsRNA-Binding ProteinsRNA, ViralViral ProteinsmiRNAsmRNA cappingPolyadenylationProtein–RNA interactionsTranslation regulationViral pathogenesis

Identifiers

PMID25630058
PMCPMC4654126
OpenAlexW2081157394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.